Novobiocin inhibits passive chromatin assembly in vitro. Sealy L, Cotten M, Chalkley R (1986) EMBO J 5: 3305-11 Novobiocin inhibits interactions required for yeast TFIIIB sequestration during stable transcription complex formation in vitro. Felts SJ, Weil PA, Chalkley R (1987) Nucleic Acids Res 15: 1493-506 Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase. Cotten M, Bresnahan D, Thompson S, Sealy L, Chalkley R (1986) Nucleic Acids Res 14: 3671-86 Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme. Corbett AH, Hong D, Osheroff N (1993) J Biol Chem 268: 14394-8 Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Robinson MJ, Corbett AH, Osheroff N (1993) Biochemistry 32: 3638-43
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.